Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.02B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.37B |
| 3 |
Cigna
CI
|
+$1.08B |
| 4 |
JPMorgan Chase
JPM
|
+$1.04B |
| 5 |
WP
Worldpay, Inc.
WP
|
+$916M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$2.24B |
| 2 |
Amazon
AMZN
|
+$2.22B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.43B |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$1.1B |
| 5 |
Boeing
BA
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.85% |
| 2 | Technology | 15.62% |
| 3 | Communication Services | 12.99% |
| 4 | Consumer Discretionary | 11.83% |
| 5 | Industrials | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Skyworks Solutions
SWKS
$10.5B
| $590M | 0.21% |
8,802,918
-4,010,594
| -31% | -$310M |
|
|
FRC
102
DELISTED
First Republic Bank
FRC
| $590M | 0.21% |
6,788,718
-243,641
| -3% | -$22.2M |
|
103
Western Union
WU
$2.23B
| $587M | 0.2% |
34,428,162
-726,749
| -2% | -$13.2M |
|
104
Edwards Lifesciences
EW
$53.6B
| $583M | 0.2% |
11,421,918
+786,120
| +7% | +$39.8M |
|
105
Boston Scientific
BSX
$74.5B
| $579M | 0.2% |
16,391,984
-3,002,544
| -15% | -$109M |
|
|
ATVI
106
DELISTED
Activision Blizzard
ATVI
| $578M | 0.2% |
12,411,069
+6,159,385
| +99% | +$369M |
|
|
K
107
DELISTED
Kellanova
K
| $578M | 0.2% |
10,793,040
-2,462,254
| -19% | -$149M |
|
108
TransDigm Group
TDG
$68.3B
| $569M | 0.2% |
1,673,166
+68,990
| +4% | +$23.7M |
|
109
Cisco
CSCO
$488B
| $568M | 0.2% |
13,097,377
-8,662,706
| -40% | -$396M |
|
|
WBA
110
DELISTED
Walgreens Boots Alliance
WBA
| $554M | 0.19% |
8,105,718
-2,805,186
| -26% | -$218M |
|
111
PNC Financial Services
PNC
$102B
| $554M | 0.19% |
4,736,605
-277,962
| -6% | -$35.5M |
|
112
TE Connectivity
TEL
$62B
| $536M | 0.19% |
7,088,247
-1,101,422
| -13% | -$84.8M |
|
113
AT&T
T
$166B
| $527M | 0.18% |
24,431,154
-16,035,822
| -40% | -$373M |
|
114
BCE
BCE
$21.6B
| $525M | 0.18% |
13,289,290
+2,891,886
| +28% | +$118M |
|
|
SCHW
115
Charles Schwab
SCHW
$189B
| $525M | 0.18% |
12,633,181
-6,610,620
| -34% | -$299M |
|
|
HOLX
116
DELISTED
Hologic
HOLX
| $515M | 0.18% |
12,524,689
-2,448,047
| -16% | -$100M |
|
117
Kimberly-Clark
KMB
$36.2B
| $513M | 0.18% |
4,501,715
-299,604
| -6% | -$33.2M |
|
118
Willis Towers Watson
WTW
$31.6B
| $511M | 0.18% |
3,366,183
+234,843
| +7% | +$35.2M |
|
119
Celanese
CE
$4.75B
| $509M | 0.18% |
5,658,503
-2,602,996
| -32% | -$255M |
|
120
Workday
WDAY
$43.3B
| $504M | 0.18% |
3,159,311
+9,271
| +0.3% | +$1.31M |
|
|
LLL
121
DELISTED
L3 Technologies, Inc.
LLL
| $503M | 0.18% |
2,894,709
+1,344,709
| +87% | +$259M |
|
122
L3Harris
LHX
$54.1B
| $499M | 0.17% |
3,709,333
+1,457,154
| +65% | +$220M |
|
123
Alcoa
AA
$13.5B
| $495M | 0.17% |
18,631,554
+6,175,581
| +50% | +$208M |
|
124
PagSeguro Digital
PAGS
$2.4B
| $489M | 0.17% |
26,129,479
+11,768,218
| +82% | +$289M |
|
125
International Flavors & Fragrances
IFF
$21.4B
| $486M | 0.17% |
3,617,095
+618,205
| +21% | +$85.6M |
|
Similar funds
Capital Research Global Investors's Q4 2018 Portfolio in Review
As of Q4 2018, Capital Research Global Investors held 457 positions worth $287B, down 17% from $344B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors's Q4 2018 filing shows 21 new, 162 increased, 169 reduced and 40 closed positions. Its largest new stake was Linde: 12,771,339 shares worth $1.99B. The largest sale was Netflix, an estimated $2.24B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q4 2018 buy was Linde: 12,771,339 shares worth $1.99B.
- Capital Research Global Investors added most to Meta Platforms (Facebook) in Q4 2018, an estimated $1.37B increase.
- Capital Research Global Investors's biggest Q4 2018 reduction was Netflix, cutting an estimated $2.24B.
- Capital Research Global Investors fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $1.1B.
- Capital Research Global Investors's ten largest holdings make up 29% of its $287B portfolio in Q4 2018.
- Capital Research Global Investors opened 21 new positions and closed 40 in Q4 2018.
- Capital Research Global Investors's portfolio value fell 17% quarter-over-quarter to $287B.
Based on Capital Research Global Investors's 13F filing for Q4 2018, filed 14 Feb 2019.